Abstract
ObjectiveTo examine how FFS Medicare utilization of endoscopy procedures for colorectal cancer (CRC) screening changed after implementation of the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) in 2006, which provided subsidized drug coverage and expanded the geographic availability of Medicare managed care plans across the US.Data Sources/Study Setting. Using secondary data from 100% FFS Medicare enrollees, we analyzed endoscopy utilization during two intervals, 2001-2005 and 2006-2009.Study designWe examined change in predictors of county-level endoscopy utilization rates based on a conceptual model of market supply and demand with spillovers from managed care practices. The equations for each period were estimated jointly in a spatial lag regression model that properly accounts for both place and time effects, allowing robust assessment of changes over time.Data collection/Extraction methodsAll Medicare FFS enrollees with both Parts A and B coverage who were age 65+, remained alive and living in the same state over the interval were included in the analyses. The later interval used a new cohort defined the same as the earlier interval. 100% Medicare denominator files were also used, providing county of address to use for county-level aggregation. The outcome variable was defined as county-level proportion of enrollees who ever used endoscopy over the interval.Principal findingsEndoscopy utilization by FFS Medicare increased, and became more accessible across the US. Medicare managed care plan spillovers onto FFS Medicare endoscopy utilization changed over time from a significant negative (restraining) effect in the early period to no significant effect by the later period.ConclusionsThe MMA eased budget constraints for seniors, making endoscopic CRC screening more affordable. The MMA policies also strengthened managed care business prospects, and enrollments in Medicare managed care escalated. The change in managed care spillover effects reflects the gradual acceptance of endoscopic CRC screening procedures, as they emerged as the gold standard during the period.
Highlights
IntroductionUtilization of endoscopic procedures (colonoscopy, sigmoidoscopy) for colorectal cancer (CRC) screening is effective in preventing precancerous tumors from developing into cancer, the utilization rate is lower than recommended guidelines [1,2,3]
The change in managed care spillover effects reflects the gradual acceptance of endoscopic colorectal cancer (CRC) screening procedures, as they emerged as the gold standard during the period
Utilization of endoscopic procedures for colorectal cancer (CRC) screening is effective in preventing precancerous tumors from developing into cancer, the utilization rate is lower than recommended guidelines [1,2,3]
Summary
Utilization of endoscopic procedures (colonoscopy, sigmoidoscopy) for colorectal cancer (CRC) screening is effective in preventing precancerous tumors from developing into cancer, the utilization rate is lower than recommended guidelines [1,2,3]. Over the six years, utilization of colonoscopy diffused rapidly across FFS Medicare markets, and came to dominate the endoscopy services. The expansion in coverage for endoscopy helped improve uptake of endoscopic screening procedures, it still left the beneficiary facing substantial out-of-pocket copayments and facility fees, and utilization rates were suboptimal according to emerging screening guidelines. In 2006, the implementation of the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) offered subsidized prescription drug packages to seniors, available to Mobley et al Health Economics Review (2017) 7:13 both traditional fee-for-service (FFS) enrollees and managed care plan enrollees. It is reasonable to expect that there might have been an increase in demand for endoscopic CRC screening after implementation of the MMA in 2006
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.